- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.12. | FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 18.11. | FIREFLY NEUROSCIENCE, INC. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 12.11. | Firefly Neuroscience, Inc. GAAP EPS of $0.20 | 5 | Seeking Alpha | ||
| 12.11. | Firefly Neuroscience, Inc.: Firefly Neuroscience Reports Third Quarter 2025 Financial Results | 139 | GlobeNewswire (Europe) | - Quarterly performance characterized by higher revenues, reduced cost structure and improved bottom line - - Successful business integration drives 10.9% sequential quarter-over-quarter EEG/ERP... ► Artikel lesen | |
| 12.11. | FIREFLY NEUROSCIENCE, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 31.10. | FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.09. | FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 05.09. | Firefly Neuroscience, Inc.: Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America | 1 | GlobeNewswire (USA) | ||
| FIREFLY NEUROSCIENCE Aktie jetzt für 0€ handeln | |||||
| 26.08. | Firefly Neuroscience, Inc.: Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen 'CLEAR' Platform | 10 | GlobeNewswire (USA) | ||
| 13.08. | FIREFLY NEUROSCIENCE, INC. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 14.07. | Firefly Neuroscience Inks Deal For Use Of Its FDA-Cleared BNA Platform In Neuroscience Research | 1 | RTTNews | ||
| 14.07. | Firefly Neuroscience stock rises on Heidelberg University collaboration | 4 | Investing.com | ||
| 14.07. | Firefly Neuroscience partners with Heidelberg on rare genetic study | 2 | Investing.com | ||
| 14.07. | Firefly Neuroscience, Inc.: Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA Platform in Groundbreaking Precision Neuroscience Research | 249 | GlobeNewswire (Europe) | - Institute of Human Genetics at Heidelberg University Hospital ongoing EEG biomarker study on 15q13.3 CNVs - - Collaboration aims to uncover novel insights into the brain's functional architecture... ► Artikel lesen | |
| 05.05. | Firefly Neuroscience, Inc.: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc. | 398 | GlobeNewswire (Europe) | Builds upon Firefly's recent acceptance into the NVIDIA Connect program Marks next major step toward building a proprietary foundation model of the human brain KENMORE, N.Y., May 05, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| 06.03. | Hemostemix Inc.: Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01 | 464 | Newsfile | Calgary, Alberta--(Newsfile Corp. - March 6, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell company that has safely treated... ► Artikel lesen | |
| 14.01. | Firefly Neuroscience, Inc.: Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA Platform | 518 | GlobeNewswire (Europe) | KENMORE, N.Y., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that... ► Artikel lesen | |
| 31.12.24 | Firefly Neuroscience, Inc.: Firefly Neuroscience Closes on Financing of up to $12.4 Million | 292 | GlobeNewswire (Europe) | TORONTO, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company developing innovative solutions... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 48,760 | +0,43 % | AT&S: Neuer Vorstand mit Fresenius-Erfahrung | Der Aufsichtsrat von AT&S beruft ein neues Vorstandsmitglied. Gerrit Steen wird den Vorstand der Gesellschaft zum 1. Februar 2026 verstärken. Der wird dann den Posten des CFO übernehmen. Steen war zuletzt... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,500 | -0,54 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen zum ersten Geschäftsquartal auf "Buy" mit einem Kursziel von 60 Euro belassen. Der Medizintechnikkonzern... ► Artikel lesen | |
| ECKERT & ZIEGLER | 14,970 | +2,39 % | Wochenend-Analyse: Eckert&Ziegler-Aktie vor entscheidender Woche - Montag könnte alles ändern! | ||
| UNITEDHEALTH | 276,20 | +0,07 % | Wochenend-Analyse: Unitedhealth-Aktie vor entscheidender Woche - Montag könnte alles ändern! | ||
| MEDTRONIC | 82,47 | -0,70 % | Dividendenbekanntmachungen (26.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALERUS FINANCIAL CORPORATION US01446U1034 0,21 USD 0,1782 EUR ALTRIA GROUP INC US02209S1033 1,06 USD 0,8999 EUR ARROWMARK FINANCIAL... ► Artikel lesen | |
| GERRESHEIMER | 26,900 | -2,68 % | INDEX-MONITOR: Zahlreiche Wechsel in MDax und SDax - Dax unverändert | ZUG (dpa-AFX) - In der zweiten und dritten deutschen Börsenreihe gibt es zum Wochenstart zahlreiche Wechsel. In den MDax werden die Börsenneulinge Aumovio und TKMS aufgenommen, während Gerresheimer... ► Artikel lesen | |
| THERMO FISHER | 491,15 | +1,76 % | Favorable Results and Improved Guidance Lifted Thermo Fisher Scientific (TMO) in Q3 | ||
| TELADOC HEALTH | 6,056 | -2,07 % | HIMS vs. TDOC: Which Telehealth Stock Looks More Compelling? | ||
| ROKU | 92,81 | -2,10 % | Nielsen To Incorporate Roku's Data Into Its Advanced Campaign Measurement And Outcome Solutions | WASHINGTON (dpa-AFX) - Nielsen, a global data, analytics, and audience measurement company, has expanded its long-term strategic partnership with Roku, Inc. (ROKU) to incorporate the latter's... ► Artikel lesen | |
| HIMS & HERS HEALTH | 29,580 | -0,30 % | Hims & Hers Expands Subscription-Led Care as Platform Engagement Grows | ||
| BECTON DICKINSON | 166,05 | -0,36 % | BD faces hernia mesh lawsuit from Tela Bio | ||
| BOSTON SCIENTIFIC | 81,60 | +0,74 % | A Strong Growth Profile Gives Boston Scientific Corp. (BSX) a Favorable Outlook | ||
| RESMED | 208,40 | 0,00 % | Resmed Gets FDA Clearance For Personalized Therapy Comfort Settings; To Be Marketed As Smart Comfort | WASHINGTON (dpa-AFX) - Resmed (RMD, RMD.AX), Monday announced it has received U.S. Food and Drug Administration (FDA) clearance for Personalized Therapy Comfort Settings (PTCS), to be marketed... ► Artikel lesen | |
| CARDINAL HEALTH | 173,65 | -0,54 % | Cardinal Health completes acquisition of Solaris Health | Adds the country's leading urology MSO with over 750 providers to Cardinal Health's leading multi-specialty MSO platform, The Specialty Alliance and brings Cardinal... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 18,780 | -1,93 % | Alignment Healthcare, Inc. - S-8, Securities to be offered to employees in employee benefit plans |
FIREFLY NEUROSCIENCE INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -1,82 % bei einem Aktienkurs von 1,080 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu FIREFLY NEUROSCIENCE INC finden Sie auf Wallstreet Online.